Status:
RECRUITING
Father-Focused Intervention for Reducing Family Violence and Symptoms in Children
Lead Sponsor:
Yale University
Collaborating Sponsors:
University of Connecticut
University of Delaware
Conditions:
Intimate Partner Violence
Child Maltreatment
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to test the efficacy of Fathers for Change (F4C) compared to standard Batterer Intervention for fathers with a history of Intimate Partner Violence. The main questio...
Detailed Description
Children's exposure to intimate partner violence (IPV), often perpetrated by fathers, has been described as a gateway to other adversity, with more than a 50% co-occurrence of direct forms of child ma...
Eligibility Criteria
Inclusion
- have at least one 6 month to 12-year-old biological child with whom they have contact;
- had an incident of IPV within the last 12 months prior to screening with their child's mother (based on court/police records, coparent or self-report);
- have a currently open or recently investigated (in the last 6 months) case with CT DCF
- are able to complete assessments in English;
- agree to have their female coparents (mother of target child) contacted as collateral informants and for consent for participation of their child. If a participant has more than one child in the age range, the youngest will be selected;
- female coparents (i.e., biological mother who need not be in a relationship with the father) consents to (at minimum) provide parent-report on child; however, may opt out of child participation. If the coparent agrees to participate by providing caregiver-report on child symptoms, but declines participation of their shared child, the father may still participate in the study if he meets eligibility criteria outlined below; thus, preventing any possible retaliation against co-parents for not consenting to child participation.
Exclusion
- Fathers will be excluded based on the following exclusion criteria:
- an active full/no contact protective order pertaining to their child because this will preclude participation in the father-child play assessment (many men will have protective orders pertaining to their partners, but it is more common for men to still be allowed contact with their children);
- physiological addiction to a substance that requires detoxification. Fathers will be evaluated using the Drug Abuse Screening Test and AUDIT. If fathers report significant difficulties with physiological withdrawal (e.g., alcohol tremors or dope sickness) they will be referred for detox services. They can be re-evaluated following a detox program with documentation from the detox center of successful completion and clean urine screen;
- cognitive impairment that will not allow for understanding of the study interventions (a mini mental state score \<25);
- current untreated psychotic disorder;
- currently suicidal or homicidal ideation based on screening using the BSI; or
- previously participated in F4C or a BIP.
Key Trial Info
Start Date :
January 11 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
1080 Patients enrolled
Trial Details
Trial ID
NCT06074068
Start Date
January 11 2024
End Date
December 31 2028
Last Update
July 29 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale
New Haven, Connecticut, United States, 06520
2
UCONN Health Center
West Hartford, Connecticut, United States, 06119